Home  |  Contact

UniProtKB/Swiss-Prot P07954: Variant p.Gly282Val

Fumarate hydratase, mitochondrial
Gene: FH
Variant information

Variant position:  282
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Valine (V) at position 282 (G282V, p.Gly282Val).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to medium size and hydrophobic (V)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In HLRCC.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  282
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  510
The length of the canonical sequence.

Location on the sequence:   IKAAMPRIYELAAGGTAVGT  G LNTRIGFAEKVAAKVAALTG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         IKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTG

Mouse                         IKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTG

Rat                           IKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTG

Pig                           IKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTG

Zebrafish                     VKASLPRVYELAAGGTAVGTGLNTRIGFAEKVADKVSALTG

Caenorhabditis elegans        VESTLPRLYQLAAGGTAVGTGLNTRKGFAEKVAATVSELTG

Slime mold                    IKDTLPRLYNLAQGGTAVGTGLNTPVGFDVDIASEVAKFTG

Baker's yeast                 VAHSLKTLSFLAQGGTAVGTGLNTKPGFDVKIAEQISKETG

Fission yeast                 INNALPRLCLLAQGGTAVGTGLNTFEGFDVKVAEKVSKLTN

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 45 – 510 Fumarate hydratase, mitochondrial
Modified residue 292 – 292 N6-acetyllysine; alternate
Modified residue 292 – 292 N6-succinyllysine; alternate


Literature citations

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Tomlinson I.P.M.; Alam N.A.; Rowan A.J.; Barclay E.; Jaeger E.E.M.; Kelsell D.; Leigh I.; Gorman P.; Lamlum H.; Rahman S.; Roylance R.R.; Olpin S.; Bevan S.; Barker K.; Hearle N.; Houlston R.S.; Kiuru M.; Lehtonen R.; Karhu A.; Vilkki S.; Laiho P.; Eklund C.; Vierimaa O.; Aittomaeki K.; Hietala M.; Sistonen P.; Paetau A.; Salovaara R.; Herva R.; Launonen V.; Aaltonen L.A.;
Nat. Genet. 30:406-410(2002)
Cited for: VARIANTS HLRCC THR-107; PRO-117; ARG-180; ARG-185; ARG-230; HIS-233; VAL-282 AND ARG-328;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.